Back to search

Peptide record

TPDB41001

P10 Anticancer standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41001
P10
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 13-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
FAAATGATPIAGR
Physicochemical Analysis
C53H86N16O16
NDCEQHLKMSWYV
A
1203.36
11.05
1
0
7
+1
-0.73
0.615
68.46
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
2
Residue Composition
number
5
A
1
R
0
N
0
D
0
C
0
E
0
Q
2
G
0
H
1
I
0
L
0
K
0
M
1
F
1
P
0
S
2
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 5 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 0 K: 0 M: 0 F: 1 P: 1 S: 0 T: 2 W: 0 Y: 0 V: 0
Chemical Descriptors
13
C53H86N16O16
1203.36
11.05
+1
-0.73
0.615
Free
L
Linear
Free
Anticancer
40S ribosomal protein fragment
Evidence Records 2 records
Evidence 1 Activity

Activity

Relative viability
Relative viability = 1.08 at 50 µg/ml
Anticancer

Target

Bone Cancer
MG-63
Bone

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Relative viability
Relative viability = 1.01 at 50 µg/ml
Anticancer

Target

Bone Cancer
U-2 OS
Bone

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023